Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Staphylococcus aureus endocarditis: a consequence of medical progress (CROSBI ID 115670)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Fowler, V.G. Jr. ; Miro, J.M. ; Hoen, B. ; Cabell, C.H. ; Abrutyn, E. ; Rubinstein, E. ; Corey, G.R. ; Spelman, D. ; Bradley, S.F. ; Baršić, Bruno et al. Staphylococcus aureus endocarditis: a consequence of medical progress // JAMA. Journal of the American Medical Association, 293 (2005), 24; 3012-21-x

Podaci o odgovornosti

Fowler, V.G. Jr. ; Miro, J.M. ; Hoen, B. ; Cabell, C.H. ; Abrutyn, E. ; Rubinstein, E. ; Corey, G.R. ; Spelman, D. ; Bradley, S.F. ; Baršić, Bruno ; Pappas, P.A. ; Anstrom, K.J. ; Wray, D. ; Fortes, C.Q. ; Anguera, I. ; Athan, E. ; Jones, P. ; van der Meer, J.T. ; Elliott, T.S. ; Levine, D.P. ; Bayer, A.S.

engleski

Staphylococcus aureus endocarditis: a consequence of medical progress

CONTEXT: The global significance of infective endocarditis (IE) caused by Staphylococcus aureus is unknown. OBJECTIVES: To document the international emergence of health care-associated S aureus IE and methicillin-resistant S aureus (MRSA) IE and to evaluate regional variation in patients with S aureus IE. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study set in 39 medical centers in 16 countries. Participants were a population of 1779 patients with definite IE as defined by Duke criteria who were enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study from June 2000 to December 2003. MAIN OUTCOME MEASURE: In-hospital mortality. RESULTS: S aureus was the most common pathogen among the 1779 cases of definite IE in the International Collaboration on Endocarditis Prospective-Cohort Study (558 patients, 31.4%). Health care-associated infection was the most common form of S aureus IE (218 patients, 39.1%), accounting for 25.9% (Australia/New Zealand) to 54.2% (Brazil) of cases. Most patients with health care-associated S aureus IE (131 patients, 60.1%) acquired the infection outside of the hospital. MRSA IE was more common in the United States (37.2%) and Brazil (37.5%) than in Europe/Middle East (23.7%) and Australia/New Zealand (15.5%, P<.001). Persistent bacteremia was independently associated with MRSA IE (odds ratio, 6.2 ; 95% confidence interval, 2.9-13.2). Patients in the United States were most likely to be hemodialysis dependent, to have diabetes, to have a presumed intravascular device source, to receive vancomycin, to be infected with MRSA, and to have persistent bacteremia (P<.001 for all comparisons). CONCLUSIONS: S aureus is the leading cause of IE in many regions of the world. Characteristics of patients with S aureus IE vary significantly by region. Further studies are required to determine the causes of regional variation.

endocarditis; Staphylococcus aureus

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

293 (24)

2005.

3012-21-x

objavljeno

0098-7484

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost